Nav: Home

MorNuCo Inc. becomes first recipient of award for research and science innovation

June 09, 2016

Dallas, Texas - June 9th, 2016 - MorNuCo Laboratories of West Lafayette, Indiana and its founders, D. James Morré, PhD, and Dorothy M. Morré, PhD, recently received the first ever L. Stephen Coles, MD, PhD Award for Research and Science Innovation in Aging and Age Management Medicine at the AMMG Conference in Orlando Florida on May 14th. This award honors the excellence and significant contributions that MorNuCo Laboratories has worked to achieve since the beginning of their research , including ENOX2 and the ONCOblot® Test. MorNuCo is elated to share this award with the public as they continue to move forward in the fight against cancer.

The award's origin spurs from Dr. Stephen L. Coles, who was a remarkable physician and researcher, who dedicated much of his life to advancing the field of age management. Sadly, the scientific and medical communities lost Dr. Coles in November of 2014. In large part, this award pays homage to Dr. Coles as a shining example of an individual with a desire to drive scientific discovery.

Upon receiving this award, Dr. D. James Morré stated, "It is a true privilege to be recognized for this award given that it is named after such an impactful person to this field."

Undoubtedly the Morrés exemplify the spirit for which this honor is awarded; a passion for discovery and the highest ethics and scientific values in conducting research and innovation within the fields of aging and age management medicine.

With the advent of technologies like the ONCOblot® Test that the Morrés have dedicated their lives to developing, physicians are increasingly finding themselves better prepared to handle age related diseases, such as cancer.

The L. Stephen Coles, MD, PhD Award for Research and Science Innovation in Aging and Age Management Medicine serves as a reminder of how much effort is being put forth to eliminate age related diseases - including cancer. It is a hopeful milestone for a cancer-free future and a wonderful award to solidify decades of hard work by the Morrés.
-end-
About ONCOblot®

The ONCOblot® Test was developed and created by Dr. D. James Morré and Dr. Dorothy M. Morré of MorNuCo, Purdue Research Park, West Lafayette, IN. The Morrés are committed to the premise that understanding cancer is the key to its conquest. The ONCOblot® test is based on more than 20 years of basic research and confirms the presence of cancer and the tissue of origin through the detection of ENOX2.

If you'd like more information about the ONCOblot® Test, please visit http://www.oncoblotlabs.com or e-mail info@oncoblotlabs.com

ONCOblot Labs

Related Cancer Articles:

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
More Cancer News and Cancer Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...